 Eric Simoes
Concepts (478)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Syncytial Virus Infections | 40 | 2018 | 128 | 5.520 |
Why?
| | Respiratory Syncytial Viruses | 18 | 2017 | 54 | 1.740 |
Why?
| | Respiratory Syncytial Virus, Human | 12 | 2018 | 74 | 1.260 |
Why?
| | Antibodies, Viral | 17 | 2025 | 625 | 1.040 |
Why?
| | Hospitalization | 19 | 2021 | 2199 | 0.910 |
Why?
| | Influenza, Human | 4 | 2024 | 622 | 0.840 |
Why?
| | Antibodies, Monoclonal | 9 | 2007 | 1430 | 0.800 |
Why?
| | Emergency Responders | 1 | 2022 | 36 | 0.760 |
Why?
| | Immunoglobulins, Intravenous | 9 | 2002 | 132 | 0.750 |
Why?
| | Macaca radiata | 8 | 2003 | 16 | 0.730 |
Why?
| | Respiratory Tract Infections | 11 | 2017 | 390 | 0.710 |
Why?
| | Otoscopes | 1 | 2021 | 4 | 0.710 |
Why?
| | Infant | 59 | 2024 | 9465 | 0.690 |
Why?
| | Pneumococcal Vaccines | 2 | 2021 | 142 | 0.650 |
Why?
| | Seasons | 9 | 2021 | 547 | 0.630 |
Why?
| | Bronchiolitis, Viral | 4 | 2013 | 12 | 0.600 |
Why?
| | Antiviral Agents | 5 | 2007 | 744 | 0.590 |
Why?
| | Respiratory Syncytial Virus Vaccines | 4 | 2013 | 36 | 0.580 |
Why?
| | Suicide | 1 | 2023 | 656 | 0.500 |
Why?
| | Infant, Premature | 10 | 2007 | 574 | 0.490 |
Why?
| | Child, Preschool | 43 | 2024 | 11074 | 0.480 |
Why?
| | Poliovirus | 5 | 2001 | 85 | 0.470 |
Why?
| | Infant, Newborn | 34 | 2025 | 6079 | 0.470 |
Why?
| | India | 12 | 2024 | 195 | 0.460 |
Why?
| | Developing Countries | 11 | 2024 | 307 | 0.450 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2025 | 394 | 0.440 |
Why?
| | Measles | 2 | 2025 | 46 | 0.400 |
Why?
| | Infant, Premature, Diseases | 4 | 2002 | 101 | 0.390 |
Why?
| | Palivizumab | 8 | 2007 | 13 | 0.390 |
Why?
| | Pneumonia | 10 | 2011 | 639 | 0.390 |
Why?
| | Incidence | 10 | 2024 | 2804 | 0.370 |
Why?
| | Population Surveillance | 4 | 2024 | 482 | 0.370 |
Why?
| | Immunoglobulin G | 4 | 2025 | 893 | 0.370 |
Why?
| | Humans | 98 | 2025 | 137585 | 0.360 |
Why?
| | Viral Vaccines | 4 | 2005 | 98 | 0.350 |
Why?
| | Immunoglobulins | 3 | 2002 | 171 | 0.350 |
Why?
| | Prospective Studies | 17 | 2024 | 7604 | 0.330 |
Why?
| | Respiratory Sounds | 4 | 2013 | 125 | 0.330 |
Why?
| | Bronchiolitis | 6 | 1999 | 80 | 0.330 |
Why?
| | Virus Diseases | 3 | 2015 | 212 | 0.320 |
Why?
| | Child | 26 | 2024 | 21935 | 0.310 |
Why?
| | Pneumococcal Infections | 2 | 2008 | 115 | 0.300 |
Why?
| | Streptococcal Infections | 2 | 2024 | 151 | 0.290 |
Why?
| | Immunization, Passive | 4 | 2002 | 90 | 0.290 |
Why?
| | Disease Outbreaks | 4 | 2021 | 395 | 0.280 |
Why?
| | Heart Defects, Congenital | 6 | 2005 | 842 | 0.280 |
Why?
| | Carotid Artery Thrombosis | 1 | 2007 | 7 | 0.280 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2007 | 9 | 0.270 |
Why?
| | Philippines | 7 | 2021 | 51 | 0.270 |
Why?
| | Mucormycosis | 1 | 2007 | 22 | 0.270 |
Why?
| | Paranasal Sinus Diseases | 1 | 2007 | 15 | 0.270 |
Why?
| | Spinal Cord | 2 | 2001 | 370 | 0.270 |
Why?
| | Carotid Artery, Internal | 1 | 2007 | 42 | 0.270 |
Why?
| | Orbital Diseases | 1 | 2007 | 32 | 0.270 |
Why?
| | Antibodies, Monoclonal, Humanized | 9 | 2007 | 804 | 0.270 |
Why?
| | Female | 45 | 2025 | 73304 | 0.260 |
Why?
| | Poliovirus Vaccine, Inactivated | 4 | 1988 | 28 | 0.260 |
Why?
| | Antifungal Agents | 1 | 2007 | 136 | 0.260 |
Why?
| | Autopsy | 2 | 2023 | 95 | 0.250 |
Why?
| | Vaccines, Attenuated | 4 | 2001 | 132 | 0.250 |
Why?
| | Triazoles | 1 | 2007 | 147 | 0.250 |
Why?
| | Infectious Disease Transmission, Vertical | 2 | 2025 | 184 | 0.250 |
Why?
| | Indonesia | 2 | 2024 | 24 | 0.240 |
Why?
| | Pneumonia, Viral | 5 | 2000 | 373 | 0.240 |
Why?
| | Hepatitis B Surface Antigens | 1 | 2025 | 24 | 0.240 |
Why?
| | Sex Work | 3 | 1993 | 22 | 0.240 |
Why?
| | Bronchopulmonary Dysplasia | 6 | 1998 | 383 | 0.230 |
Why?
| | Child, Hospitalized | 1 | 2005 | 49 | 0.230 |
Why?
| | Male | 39 | 2025 | 67762 | 0.230 |
Why?
| | Asthma | 4 | 2002 | 2295 | 0.230 |
Why?
| | Hepatitis B | 1 | 2025 | 70 | 0.220 |
Why?
| | Child Health Services | 2 | 2003 | 184 | 0.220 |
Why?
| | Community-Acquired Infections | 3 | 2015 | 174 | 0.210 |
Why?
| | Metapneumovirus | 2 | 2013 | 16 | 0.210 |
Why?
| | Streptococcus agalactiae | 1 | 2024 | 93 | 0.200 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2024 | 148 | 0.200 |
Why?
| | Leukotriene Antagonists | 1 | 2003 | 43 | 0.200 |
Why?
| | Fetal Blood | 1 | 2025 | 327 | 0.200 |
Why?
| | Measles Vaccine | 3 | 2025 | 21 | 0.200 |
Why?
| | Severity of Illness Index | 7 | 2008 | 2828 | 0.200 |
Why?
| | Longitudinal Studies | 5 | 2023 | 2844 | 0.190 |
Why?
| | Acetates | 1 | 2003 | 99 | 0.190 |
Why?
| | Adult | 18 | 2025 | 37929 | 0.190 |
Why?
| | Bronchial Provocation Tests | 1 | 2002 | 51 | 0.190 |
Why?
| | Poliomyelitis | 2 | 2001 | 37 | 0.190 |
Why?
| | Young Adult | 6 | 2025 | 13209 | 0.190 |
Why?
| | Developed Countries | 1 | 2002 | 39 | 0.190 |
Why?
| | Adolescent | 11 | 2025 | 21513 | 0.190 |
Why?
| | Quinolines | 1 | 2003 | 178 | 0.180 |
Why?
| | Risk Factors | 18 | 2017 | 10388 | 0.180 |
Why?
| | Poliovirus Vaccine, Oral | 1 | 2001 | 25 | 0.180 |
Why?
| | Otoscopy | 1 | 2021 | 8 | 0.180 |
Why?
| | Altitude | 1 | 2006 | 488 | 0.180 |
Why?
| | Cause of Death | 1 | 2023 | 434 | 0.180 |
Why?
| | Cross Infection | 2 | 2013 | 256 | 0.180 |
Why?
| | Disease Models, Animal | 5 | 2003 | 4295 | 0.180 |
Why?
| | Immunoglobulin A | 1 | 2022 | 211 | 0.180 |
Why?
| | Peripheral Nerves | 1 | 2001 | 65 | 0.170 |
Why?
| | Length of Stay | 4 | 2005 | 1215 | 0.170 |
Why?
| | Mothers | 2 | 2005 | 754 | 0.170 |
Why?
| | Africa South of the Sahara | 3 | 2025 | 48 | 0.170 |
Why?
| | Hospital Charges | 1 | 2000 | 44 | 0.170 |
Why?
| | Denmark | 3 | 2009 | 46 | 0.170 |
Why?
| | Diphtheria Toxoid | 3 | 1988 | 11 | 0.160 |
Why?
| | Pertussis Vaccine | 3 | 1988 | 22 | 0.150 |
Why?
| | Tetanus Toxoid | 3 | 1988 | 35 | 0.150 |
Why?
| | Environmental Exposure | 1 | 2003 | 579 | 0.150 |
Why?
| | Parvovirus B19, Human | 1 | 2018 | 3 | 0.150 |
Why?
| | Parvoviridae Infections | 1 | 2018 | 12 | 0.150 |
Why?
| | HN Protein | 1 | 1998 | 5 | 0.140 |
Why?
| | Colorado | 4 | 2021 | 4565 | 0.140 |
Why?
| | Vaccination | 3 | 2022 | 1381 | 0.140 |
Why?
| | Cost of Illness | 1 | 2000 | 308 | 0.140 |
Why?
| | Respiratory Tract Diseases | 1 | 1999 | 184 | 0.140 |
Why?
| | Anxiety | 1 | 2005 | 1035 | 0.140 |
Why?
| | Virus Replication | 4 | 2003 | 483 | 0.140 |
Why?
| | Referral and Consultation | 1 | 2003 | 786 | 0.140 |
Why?
| | Rickets | 1 | 1997 | 10 | 0.140 |
Why?
| | Caregivers | 1 | 2005 | 877 | 0.140 |
Why?
| | Viral Proteins | 2 | 1998 | 342 | 0.140 |
Why?
| | Air | 1 | 1997 | 37 | 0.130 |
Why?
| | Lung Diseases | 1 | 2003 | 767 | 0.130 |
Why?
| | Ventilator Weaning | 1 | 1997 | 36 | 0.130 |
Why?
| | Stress, Psychological | 1 | 2005 | 1100 | 0.130 |
Why?
| | RNA, Viral | 3 | 2001 | 656 | 0.130 |
Why?
| | Education, Nursing, Continuing | 1 | 1997 | 53 | 0.130 |
Why?
| | Pregnancy | 6 | 2025 | 6763 | 0.130 |
Why?
| | Acquired Immunodeficiency Syndrome | 2 | 1987 | 230 | 0.120 |
Why?
| | Neutralization Tests | 3 | 2001 | 75 | 0.120 |
Why?
| | Postpartum Period | 1 | 2018 | 340 | 0.120 |
Why?
| | Pharyngeal Diseases | 1 | 1995 | 16 | 0.120 |
Why?
| | In Situ Hybridization | 3 | 2001 | 316 | 0.120 |
Why?
| | Asia | 2 | 2025 | 71 | 0.120 |
Why?
| | Jugular Veins | 1 | 1995 | 41 | 0.110 |
Why?
| | Mouth | 1 | 1995 | 87 | 0.110 |
Why?
| | Haemophilus Infections | 1 | 1995 | 42 | 0.110 |
Why?
| | Abscess | 1 | 1995 | 75 | 0.110 |
Why?
| | Cerebral Aqueduct | 1 | 1994 | 4 | 0.110 |
Why?
| | Infectious Mononucleosis | 1 | 1994 | 10 | 0.110 |
Why?
| | Double-Blind Method | 8 | 2007 | 1993 | 0.110 |
Why?
| | Respirovirus Infections | 2 | 1993 | 13 | 0.110 |
Why?
| | Otitis Media | 1 | 1996 | 165 | 0.110 |
Why?
| | Gestational Age | 3 | 2005 | 910 | 0.110 |
Why?
| | Nucleoproteins | 1 | 2013 | 27 | 0.100 |
Why?
| | Human bocavirus | 1 | 2013 | 1 | 0.100 |
Why?
| | HIV Infections | 3 | 2018 | 2836 | 0.100 |
Why?
| | Triplets | 1 | 1993 | 3 | 0.100 |
Why?
| | HIV Antibodies | 1 | 1993 | 62 | 0.100 |
Why?
| | South Africa | 3 | 2024 | 222 | 0.100 |
Why?
| | Prevalence | 3 | 2025 | 2734 | 0.100 |
Why?
| | Models, Statistical | 1 | 2017 | 669 | 0.100 |
Why?
| | Oropharynx | 1 | 2013 | 46 | 0.100 |
Why?
| | Hydrocephalus | 1 | 1994 | 106 | 0.100 |
Why?
| | Primary Health Care | 1 | 2003 | 1738 | 0.100 |
Why?
| | Pediatric Nursing | 1 | 1992 | 42 | 0.100 |
Why?
| | Disease Management | 1 | 1997 | 628 | 0.100 |
Why?
| | Cohort Studies | 4 | 2018 | 5742 | 0.090 |
Why?
| | Vaccines, Inactivated | 2 | 2003 | 68 | 0.090 |
Why?
| | Community Health Workers | 1 | 1992 | 62 | 0.090 |
Why?
| | Encephalitis | 1 | 1994 | 136 | 0.090 |
Why?
| | Diseases in Twins | 1 | 1993 | 169 | 0.090 |
Why?
| | Case-Control Studies | 5 | 2018 | 3556 | 0.090 |
Why?
| | Respiratory Physiological Phenomena | 1 | 1991 | 31 | 0.090 |
Why?
| | Pneumonia, Bacterial | 2 | 2009 | 116 | 0.090 |
Why?
| | Europe | 2 | 2003 | 414 | 0.090 |
Why?
| | Respiratory Function Tests | 3 | 2002 | 600 | 0.090 |
Why?
| | Aged | 6 | 2024 | 23961 | 0.090 |
Why?
| | Thrombosis | 1 | 1995 | 371 | 0.090 |
Why?
| | Ulnar Nerve | 2 | 2001 | 15 | 0.090 |
Why?
| | Genes, Viral | 1 | 1991 | 88 | 0.090 |
Why?
| | Age Distribution | 4 | 2007 | 392 | 0.090 |
Why?
| | Breast Feeding | 2 | 2003 | 440 | 0.090 |
Why?
| | Time Factors | 7 | 2018 | 6828 | 0.080 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 812 | 0.080 |
Why?
| | Retrospective Studies | 6 | 2023 | 15657 | 0.080 |
Why?
| | Socioeconomic Factors | 2 | 2006 | 1289 | 0.080 |
Why?
| | DNA, Viral | 2 | 2025 | 364 | 0.080 |
Why?
| | Middle Aged | 6 | 2024 | 33479 | 0.080 |
Why?
| | Measles virus | 2 | 2025 | 16 | 0.080 |
Why?
| | Logistic Models | 4 | 2009 | 2074 | 0.080 |
Why?
| | Clinical Competence | 1 | 1997 | 1118 | 0.080 |
Why?
| | Lung | 2 | 2001 | 4060 | 0.070 |
Why?
| | Algorithms | 3 | 2009 | 1704 | 0.070 |
Why?
| | Sensitivity and Specificity | 5 | 2007 | 1946 | 0.070 |
Why?
| | Single-Blind Method | 3 | 1998 | 282 | 0.070 |
Why?
| | Protein Biosynthesis | 1 | 1991 | 433 | 0.070 |
Why?
| | Mozambique | 2 | 2024 | 7 | 0.070 |
Why?
| | Animals | 10 | 2004 | 36940 | 0.070 |
Why?
| | Maternal-Fetal Exchange | 1 | 2009 | 165 | 0.070 |
Why?
| | Respiration | 3 | 1997 | 199 | 0.070 |
Why?
| | Mucor | 1 | 2007 | 7 | 0.070 |
Why?
| | Global Health | 2 | 2017 | 386 | 0.070 |
Why?
| | United States | 7 | 2007 | 14841 | 0.070 |
Why?
| | HIV-1 | 1 | 1993 | 864 | 0.070 |
Why?
| | Ethiopia | 2 | 1997 | 41 | 0.070 |
Why?
| | Debridement | 1 | 2007 | 81 | 0.070 |
Why?
| | Central Nervous System Bacterial Infections | 1 | 2006 | 5 | 0.070 |
Why?
| | Meningitis, Bacterial | 1 | 2007 | 47 | 0.070 |
Why?
| | Weather | 1 | 2007 | 40 | 0.070 |
Why?
| | Reference Values | 2 | 2007 | 816 | 0.060 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2007 | 46 | 0.060 |
Why?
| | Probability | 1 | 2007 | 304 | 0.060 |
Why?
| | Cell Line | 3 | 2004 | 2847 | 0.060 |
Why?
| | Rectum | 2 | 2024 | 185 | 0.060 |
Why?
| | Deltaretrovirus | 1 | 1985 | 12 | 0.060 |
Why?
| | Secondary Prevention | 1 | 2007 | 233 | 0.060 |
Why?
| | Predictive Value of Tests | 5 | 2009 | 2031 | 0.060 |
Why?
| | Hepatitis B e Antigens | 1 | 2025 | 4 | 0.060 |
Why?
| | Convalescence | 1 | 2005 | 17 | 0.060 |
Why?
| | Asia, Southeastern | 1 | 2025 | 13 | 0.060 |
Why?
| | DNA, Bacterial | 1 | 2007 | 337 | 0.060 |
Why?
| | Immunity, Maternally-Acquired | 1 | 2025 | 19 | 0.060 |
Why?
| | Hepatitis B virus | 1 | 2025 | 40 | 0.060 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 786 | 0.060 |
Why?
| | Athetosis | 1 | 2005 | 7 | 0.060 |
Why?
| | Chorea | 1 | 2005 | 13 | 0.060 |
Why?
| | Biomedical Research | 1 | 2011 | 692 | 0.060 |
Why?
| | Cyanosis | 2 | 2009 | 16 | 0.060 |
Why?
| | Antibodies, Bacterial | 2 | 2000 | 146 | 0.060 |
Why?
| | Bhutan | 1 | 2024 | 3 | 0.060 |
Why?
| | Pediatrics | 3 | 2001 | 1101 | 0.060 |
Why?
| | Seroepidemiologic Studies | 1 | 2025 | 165 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 767 | 0.060 |
Why?
| | Fruit | 2 | 1996 | 140 | 0.060 |
Why?
| | Paramyxoviridae | 1 | 2004 | 2 | 0.060 |
Why?
| | Blood Donors | 1 | 1985 | 105 | 0.060 |
Why?
| | Paramyxoviridae Infections | 1 | 2004 | 13 | 0.060 |
Why?
| | Vegetables | 2 | 1996 | 157 | 0.060 |
Why?
| | Africa | 1 | 2024 | 108 | 0.050 |
Why?
| | Maxillary Sinus | 1 | 2004 | 11 | 0.050 |
Why?
| | Maxillary Sinusitis | 1 | 2004 | 7 | 0.050 |
Why?
| | Family Health | 1 | 2005 | 196 | 0.050 |
Why?
| | Sinusitis | 2 | 1999 | 221 | 0.050 |
Why?
| | Orthomyxoviridae | 1 | 2004 | 40 | 0.050 |
Why?
| | Hypothermia, Induced | 1 | 2005 | 80 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2007 | 1509 | 0.050 |
Why?
| | Orthomyxoviridae Infections | 1 | 2004 | 67 | 0.050 |
Why?
| | Equipment and Supplies | 1 | 2003 | 42 | 0.050 |
Why?
| | Data Interpretation, Statistical | 1 | 2005 | 363 | 0.050 |
Why?
| | U937 Cells | 1 | 2003 | 24 | 0.050 |
Why?
| | Nasal Mucosa | 1 | 2004 | 107 | 0.050 |
Why?
| | Viral Load | 1 | 2025 | 466 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2005 | 347 | 0.050 |
Why?
| | Acute Disease | 3 | 2013 | 1007 | 0.050 |
Why?
| | Spain | 1 | 2003 | 41 | 0.050 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 3 | 1988 | 25 | 0.050 |
Why?
| | Blood Transfusion | 1 | 1985 | 325 | 0.050 |
Why?
| | Cyclopropanes | 1 | 2003 | 90 | 0.050 |
Why?
| | Steroids | 2 | 2001 | 167 | 0.050 |
Why?
| | Cell Count | 2 | 2004 | 324 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 2057 | 0.050 |
Why?
| | Demography | 1 | 2003 | 291 | 0.050 |
Why?
| | Odds Ratio | 2 | 1997 | 1070 | 0.050 |
Why?
| | Malnutrition | 1 | 2003 | 83 | 0.050 |
Why?
| | Climate | 1 | 2003 | 94 | 0.050 |
Why?
| | Vagina | 1 | 2024 | 187 | 0.050 |
Why?
| | Geography | 1 | 2003 | 200 | 0.050 |
Why?
| | Sulfides | 1 | 2003 | 99 | 0.050 |
Why?
| | Rhinitis | 1 | 2004 | 158 | 0.050 |
Why?
| | Japan | 1 | 2002 | 115 | 0.050 |
Why?
| | Morbidity | 1 | 2003 | 324 | 0.050 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2002 | 137 | 0.050 |
Why?
| | Phylogeny | 2 | 2018 | 904 | 0.050 |
Why?
| | Intensive Care Units, Neonatal | 2 | 1997 | 257 | 0.050 |
Why?
| | Drug Combinations | 3 | 1988 | 343 | 0.050 |
Why?
| | Vaccines, Synthetic | 1 | 2002 | 126 | 0.050 |
Why?
| | Vaccines, Subunit | 1 | 2001 | 49 | 0.050 |
Why?
| | Body Weight | 1 | 1986 | 985 | 0.050 |
Why?
| | Formaldehyde | 1 | 2001 | 63 | 0.050 |
Why?
| | Treatment Outcome | 7 | 2007 | 10811 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2007 | 5131 | 0.040 |
Why?
| | Administration, Inhalation | 2 | 2001 | 688 | 0.040 |
Why?
| | Hospitals, District | 1 | 2001 | 6 | 0.040 |
Why?
| | Virus Shedding | 1 | 2001 | 48 | 0.040 |
Why?
| | Models, Immunological | 1 | 2001 | 100 | 0.040 |
Why?
| | Health Services Research | 1 | 2003 | 404 | 0.040 |
Why?
| | Canada | 1 | 2002 | 418 | 0.040 |
Why?
| | Macaca | 1 | 1980 | 56 | 0.040 |
Why?
| | Poverty | 1 | 2024 | 521 | 0.040 |
Why?
| | Serum Albumin | 1 | 2001 | 150 | 0.040 |
Why?
| | Nerve Fibers, Myelinated | 1 | 1980 | 47 | 0.040 |
Why?
| | Hospitals, Teaching | 1 | 2001 | 118 | 0.040 |
Why?
| | Viremia | 1 | 2001 | 138 | 0.040 |
Why?
| | Mortality | 1 | 2003 | 362 | 0.040 |
Why?
| | Oxygen | 1 | 2005 | 931 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 852 | 0.040 |
Why?
| | Influenza B virus | 2 | 2004 | 44 | 0.040 |
Why?
| | Tobacco Smoke Pollution | 1 | 2003 | 261 | 0.040 |
Why?
| | Nasopharynx | 2 | 1998 | 76 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 2 | 2001 | 496 | 0.040 |
Why?
| | Bacteria | 1 | 2007 | 858 | 0.040 |
Why?
| | Neuroglia | 1 | 2001 | 173 | 0.040 |
Why?
| | Genotype | 1 | 2025 | 1916 | 0.040 |
Why?
| | Wrist | 1 | 1980 | 54 | 0.040 |
Why?
| | BCG Vaccine | 1 | 1999 | 24 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5472 | 0.040 |
Why?
| | Intensive Care Units, Pediatric | 2 | 1998 | 233 | 0.040 |
Why?
| | Sex Factors | 2 | 2003 | 2071 | 0.040 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2000 | 127 | 0.040 |
Why?
| | Influenza A virus | 2 | 2004 | 107 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 1999 | 206 | 0.040 |
Why?
| | Fever | 2 | 2018 | 306 | 0.040 |
Why?
| | Hand | 1 | 1980 | 156 | 0.040 |
Why?
| | Cardiac Surgical Procedures | 1 | 2005 | 530 | 0.040 |
Why?
| | Age Factors | 4 | 2006 | 3295 | 0.040 |
Why?
| | Patient Discharge | 1 | 2005 | 897 | 0.040 |
Why?
| | Hospital Mortality | 2 | 2017 | 911 | 0.040 |
Why?
| | Antigens, Viral | 1 | 1999 | 178 | 0.040 |
Why?
| | Parvovirus | 1 | 2018 | 13 | 0.040 |
Why?
| | Risk Assessment | 1 | 2007 | 3457 | 0.030 |
Why?
| | Research | 1 | 2001 | 451 | 0.030 |
Why?
| | Vaccines, Combined | 2 | 1988 | 48 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 1998 | 390 | 0.030 |
Why?
| | Nutrition Disorders | 1 | 1997 | 23 | 0.030 |
Why?
| | Viral Envelope Proteins | 1 | 1998 | 84 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2003 | 827 | 0.030 |
Why?
| | Child Nutrition Disorders | 1 | 1997 | 20 | 0.030 |
Why?
| | World Health Organization | 2 | 2008 | 123 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2000 | 591 | 0.030 |
Why?
| | Bacterial Infections | 2 | 2007 | 250 | 0.030 |
Why?
| | Practice Guidelines as Topic | 2 | 2009 | 1587 | 0.030 |
Why?
| | Animals, Newborn | 1 | 1999 | 844 | 0.030 |
Why?
| | Nursing Assessment | 1 | 1997 | 59 | 0.030 |
Why?
| | Dehydration | 1 | 1997 | 51 | 0.030 |
Why?
| | Neutrophils | 1 | 2002 | 1238 | 0.030 |
Why?
| | Birth Weight | 2 | 1993 | 516 | 0.030 |
Why?
| | Pulmonary Alveoli | 1 | 1999 | 405 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 1999 | 652 | 0.030 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 1997 | 108 | 0.030 |
Why?
| | Macrophages, Alveolar | 1 | 1999 | 391 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2001 | 642 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2003 | 986 | 0.030 |
Why?
| | Bangladesh | 1 | 2015 | 56 | 0.030 |
Why?
| | Comorbidity | 1 | 2000 | 1622 | 0.030 |
Why?
| | Oxygen Inhalation Therapy | 1 | 1997 | 157 | 0.030 |
Why?
| | Lung Abscess | 1 | 1995 | 7 | 0.030 |
Why?
| | Nasal Cavity | 1 | 2015 | 52 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2007 | 3566 | 0.030 |
Why?
| | Epidemiological Monitoring | 1 | 2015 | 60 | 0.030 |
Why?
| | Blood | 1 | 2015 | 107 | 0.030 |
Why?
| | Cerebrospinal Fluid | 1 | 2015 | 92 | 0.030 |
Why?
| | Nutritional Status | 1 | 1997 | 350 | 0.030 |
Why?
| | Prognosis | 1 | 2003 | 4030 | 0.030 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 1994 | 36 | 0.030 |
Why?
| | Eating | 2 | 1999 | 380 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 1997 | 696 | 0.030 |
Why?
| | Ribavirin | 1 | 1994 | 91 | 0.030 |
Why?
| | Opportunistic Infections | 1 | 1993 | 46 | 0.030 |
Why?
| | Counseling | 1 | 1997 | 391 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 1994 | 245 | 0.030 |
Why?
| | Herpesvirus 4, Human | 1 | 1994 | 166 | 0.030 |
Why?
| | Crowding | 1 | 1993 | 35 | 0.020 |
Why?
| | Influenza Vaccines | 1 | 1998 | 539 | 0.020 |
Why?
| | Hospitals, University | 1 | 1993 | 182 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 1997 | 645 | 0.020 |
Why?
| | Neurons | 1 | 2001 | 1590 | 0.020 |
Why?
| | Radiography | 3 | 2008 | 822 | 0.020 |
Why?
| | Methods | 1 | 1991 | 65 | 0.020 |
Why?
| | Sexual Partners | 1 | 1993 | 186 | 0.020 |
Why?
| | RNA, Messenger | 1 | 1999 | 2833 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 1991 | 25 | 0.020 |
Why?
| | Immunocompromised Host | 1 | 2013 | 202 | 0.020 |
Why?
| | Psychomotor Agitation | 1 | 1991 | 71 | 0.020 |
Why?
| | Rural Population | 1 | 2015 | 563 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 976 | 0.020 |
Why?
| | Inflammation | 1 | 2001 | 2837 | 0.020 |
Why?
| | Feeding Behavior | 1 | 1996 | 654 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1991 | 375 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1991 | 534 | 0.020 |
Why?
| | Chronic Disease | 3 | 2004 | 1793 | 0.020 |
Why?
| | Rural Health | 1 | 2009 | 80 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 1993 | 508 | 0.020 |
Why?
| | Typhoid-Paratyphoid Vaccines | 1 | 1989 | 4 | 0.020 |
Why?
| | Salmonella typhi | 1 | 1989 | 13 | 0.020 |
Why?
| | HeLa Cells | 1 | 1991 | 636 | 0.020 |
Why?
| | Typhoid Fever | 1 | 1989 | 10 | 0.020 |
Why?
| | Sexual Behavior | 1 | 1993 | 485 | 0.020 |
Why?
| | Transfection | 1 | 1991 | 945 | 0.020 |
Why?
| | Genetic Variation | 1 | 2013 | 991 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 1991 | 728 | 0.020 |
Why?
| | Meteorological Concepts | 1 | 2007 | 6 | 0.020 |
Why?
| | Kinetics | 1 | 1991 | 1670 | 0.020 |
Why?
| | Buchnera | 1 | 2007 | 1 | 0.020 |
Why?
| | Half-Life | 2 | 1999 | 164 | 0.020 |
Why?
| | Base Sequence | 1 | 1991 | 2181 | 0.020 |
Why?
| | Humidity | 1 | 2007 | 50 | 0.020 |
Why?
| | Diet | 1 | 1995 | 1278 | 0.020 |
Why?
| | Hypersensitivity, Immediate | 1 | 2006 | 44 | 0.020 |
Why?
| | Bacteriological Techniques | 1 | 2007 | 73 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1991 | 2900 | 0.020 |
Why?
| | Weaning | 1 | 1986 | 47 | 0.020 |
Why?
| | Anti-Bacterial Agents | 3 | 2007 | 1809 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2007 | 142 | 0.020 |
Why?
| | Models, Molecular | 1 | 1991 | 1570 | 0.020 |
Why?
| | Evaluation Studies as Topic | 1 | 1985 | 180 | 0.010 |
Why?
| | Antibody Formation | 1 | 1987 | 298 | 0.010 |
Why?
| | Infant, Low Birth Weight | 1 | 1986 | 141 | 0.010 |
Why?
| | Sleep | 1 | 1991 | 755 | 0.010 |
Why?
| | Nigeria | 1 | 2005 | 23 | 0.010 |
Why?
| | Acid-Base Equilibrium | 1 | 2005 | 28 | 0.010 |
Why?
| | Parainfluenza Virus 2, Human | 1 | 2004 | 3 | 0.010 |
Why?
| | Parainfluenza Virus 1, Human | 1 | 2004 | 3 | 0.010 |
Why?
| | Parainfluenza Virus 3, Human | 1 | 2004 | 5 | 0.010 |
Why?
| | Nasal Lavage Fluid | 1 | 2004 | 14 | 0.010 |
Why?
| | Virus Cultivation | 1 | 2004 | 29 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2007 | 1316 | 0.010 |
Why?
| | Exocrine Glands | 1 | 2004 | 5 | 0.010 |
Why?
| | Adenoviruses, Human | 1 | 2004 | 27 | 0.010 |
Why?
| | Basement Membrane | 1 | 2004 | 35 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 2007 | 396 | 0.010 |
Why?
| | Risk | 1 | 1987 | 912 | 0.010 |
Why?
| | Immunization Schedule | 1 | 1985 | 197 | 0.010 |
Why?
| | Body Temperature | 1 | 2005 | 222 | 0.010 |
Why?
| | Temperature | 1 | 2007 | 679 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 1062 | 0.010 |
Why?
| | Immunization | 1 | 1986 | 411 | 0.010 |
Why?
| | Plasma Cells | 1 | 2004 | 71 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 1996 | 2111 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2005 | 560 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1999 | 3715 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2005 | 267 | 0.010 |
Why?
| | Cardiopulmonary Bypass | 1 | 2005 | 209 | 0.010 |
Why?
| | Survival Rate | 1 | 2007 | 1972 | 0.010 |
Why?
| | Esophagus | 1 | 2005 | 255 | 0.010 |
Why?
| | Escherichia coli | 1 | 2007 | 815 | 0.010 |
Why?
| | Phenotype | 1 | 1991 | 3196 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1477 | 0.010 |
Why?
| | Lymphocytes | 1 | 2004 | 397 | 0.010 |
Why?
| | Eosinophils | 1 | 2004 | 332 | 0.010 |
Why?
| | Neoplasms | 1 | 1996 | 2671 | 0.010 |
Why?
| | Metacarpophalangeal Joint | 1 | 1980 | 15 | 0.010 |
Why?
| | Biopsy | 1 | 2004 | 1129 | 0.010 |
Why?
| | Polysaccharides, Bacterial | 1 | 2000 | 70 | 0.010 |
Why?
| | Medical Records | 1 | 2000 | 177 | 0.010 |
Why?
| | Nasal Decongestants | 1 | 1999 | 8 | 0.010 |
Why?
| | Placebos | 1 | 1999 | 199 | 0.010 |
Why?
| | Glutamate Decarboxylase | 1 | 1999 | 170 | 0.010 |
Why?
| | Insulin Antibodies | 1 | 1999 | 105 | 0.010 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 1999 | 40 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 1999 | 129 | 0.010 |
Why?
| | C-Peptide | 1 | 1999 | 163 | 0.010 |
Why?
| | Triage | 1 | 2001 | 222 | 0.010 |
Why?
| | Bacteremia | 1 | 2000 | 214 | 0.010 |
Why?
| | Radiography, Thoracic | 1 | 1997 | 167 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 1999 | 1236 | 0.010 |
Why?
| | Physical Examination | 1 | 1997 | 241 | 0.010 |
Why?
| | Recurrence | 1 | 1999 | 1060 | 0.010 |
Why?
| | Therapeutic Equivalency | 1 | 1995 | 32 | 0.010 |
Why?
| | Patient Selection | 1 | 1999 | 696 | 0.010 |
Why?
| | Diet Surveys | 1 | 1995 | 95 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 1999 | 740 | 0.010 |
Why?
| | Nutrition Surveys | 1 | 1996 | 266 | 0.010 |
Why?
| | Random Allocation | 1 | 1995 | 353 | 0.010 |
Why?
| | Telephone | 1 | 1995 | 173 | 0.010 |
Why?
| | Marriage | 1 | 1995 | 121 | 0.010 |
Why?
| | Life Style | 1 | 1996 | 490 | 0.010 |
Why?
| | Islets of Langerhans | 1 | 1999 | 803 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 1997 | 1483 | 0.010 |
Why?
| | Autoantibodies | 1 | 1999 | 1496 | 0.010 |
Why?
| | Tropical Climate | 1 | 1991 | 19 | 0.010 |
Why?
| | Pleura | 1 | 1991 | 23 | 0.010 |
Why?
| | Acetaminophen | 1 | 1994 | 268 | 0.010 |
Why?
| | Pharynx | 1 | 1991 | 59 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1992 | 271 | 0.010 |
Why?
| | Health Behavior | 1 | 1996 | 762 | 0.010 |
Why?
| | Blood Glucose | 1 | 1999 | 2186 | 0.000 |
Why?
| | Emergency Service, Hospital | 1 | 2001 | 2069 | 0.000 |
Why?
| | Reproducibility of Results | 1 | 1997 | 3284 | 0.000 |
Why?
| | Alcohol Drinking | 1 | 1996 | 828 | 0.000 |
Why?
| | Monitoring, Physiologic | 1 | 1991 | 275 | 0.000 |
Why?
| | Insulin | 1 | 1999 | 2409 | 0.000 |
Why?
| | Injections, Subcutaneous | 1 | 1989 | 157 | 0.000 |
Why?
| | Thorax | 1 | 1988 | 50 | 0.000 |
Why?
| | Antigens, Bacterial | 1 | 1989 | 127 | 0.000 |
Why?
| | Smoking | 1 | 1996 | 1627 | 0.000 |
Why?
| | Body Mass Index | 1 | 1996 | 2389 | 0.000 |
Why?
| | Sepsis | 1 | 1991 | 617 | 0.000 |
Why?
| | Exercise | 1 | 1996 | 2057 | 0.000 |
Why?
|
|
Simoes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|